Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Referenceopen allclose all

Reference Type:
other: Authoritative data base
Title:
HSDB Number 209
Year:
2011
Bibliographic source:
HSDB (Hazardous Substances Data Bank); US national Library of Medicine reviewed by SRC
Reference Type:
other: Authoritative data base
Title:
No information
Year:
2012
Bibliographic source:
NTP (National Toxicological Program)by Agency for Toxic Substances and Disease Registry; Division of Toxicology/Toxicology Information Branch, 1600 Clifton Road NE, E-29, Atlanta, Georgia 30333

Materials and methods

Objective of study:
excretion
Test guideline
Qualifier:
according to guideline
Guideline:
other:
Principles of method if other than guideline:
Data is from HSDB & NTP
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Cinnamaldehyde
EC Number:
203-213-9
EC Name:
Cinnamaldehyde
Cas Number:
104-55-2
Molecular formula:
C9H8O
IUPAC Name:
3-phenylacrylaldehyde
Test material form:
liquid: viscous
Details on test material:
- Name of test material (as cited in study report): cinnamaldehyde
- Substance type: Organic
- Physical state: Liquid
Radiolabelling:
yes

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Duration and frequency of treatment / exposure:
7 days
Doses / concentrations
Remarks:
Doses / Concentrations:
5, 50, or 500 mg/kg bw
No. of animals per sex per dose / concentration:
8/group
Details on dosing and sampling:
Twenty-four hours later, animals in each group received a single oral dose of [3-(14)C]cinnamaldehyde equivalent to the pretreatment level. At 50 and 500 mg/kg bw, radioactivity could be measured in animals terminated 3 days after dosing.

Results and discussion

Main ADME resultsopen allclose all
Type:
absorption
Results:
Cinnamaldehyde is easy absored within the body rapidly and further distributed in various organs
Type:
distribution
Results:
Radioactivity is distributed primarily to the gastrointestinal tract, kidneys, and liver, after single- or multiple-dose oral administration. At all dose levels, a small amount of the dose is distributed to the fat.
Type:
metabolism
Results:
In the high dose pretreatment group, benzoic acid is the major metabolite, suggesting that saturation of the glycine conjugation pathway occurs at repeated high dose levels of cinnamaldehyde.
Type:
excretion
Results:
After 24 hr, >80% of the radioactivity is recovered in the urine and <7% in the feces from all groups of rats, regardless of dose level.

Toxicokinetic / pharmacokinetic studies

Details on distribution in tissues:
Radioactivity is distributed primarily to the gastrointestinal tract, kidneys, and liver, after single- or multiple-dose oral administration. At all dose levels, a small amount of the dose is distributed to the fat.

Details on excretion:
After 24 hr, >80% of the radioactivity is recovered in the urine and <7% in the feces from all groups of rats, regardless of dose level.

Metabolite characterisation studies

Details on metabolites:
Except for the high dose pretreatment group, the major urinary metabolite is hippuric acid, accompanied by small amounts of cinnamic and benzoic acid. In the high dose pretreatment group, benzoic acid is the major metabolite, suggesting that saturation of the glycine conjugation pathway occurs at repeated high dose levels of cinnamaldehyde.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): no bioaccumulation potential based on study results
Based on the study conducted on male rat on cinnamaldehyde by oral route the toxicokinetcs are found be as follows

Absorption:
Cinnamaldehyde is easy absored within the body rapidly and further distributed in various organs

Dirtibution:
Radioactivity is distributed primarily to the gastrointestinal tract, kidneys, and liver, after single- or multiple-dose oral administration. At all dose levels, a small amount of the dose is distributed to the fat.

Metabolism:
In the high dose pretreatment group, benzoic acid is the major metabolite, suggesting that saturation of the glycine conjugation pathway occurs at repeated high dose levels of cinnamaldehyde.

Execrition
After 24 hr, >80% of the radioactivity is recovered in the urine and <7% in the feces from all groups of rats, regardless of dose level.
Executive summary:

Based on the study conducted on male rat on cinnamaldehyde by oral route the toxicokinetcs are found be as follows

Absorption:

Cinnamaldehyde is easy absored within the body rapidly and further distributed in various organs

Dirtibution:

Radioactivity is distributed primarily to the gastrointestinal tract, kidneys, and liver, after single- or multiple-dose oral administration. At all dose levels, a small amount of the dose is distributed to the fat.

Metabolism:

In the high dose pretreatment group, benzoic acid is the major metabolite, suggesting that saturation of the glycine conjugation pathway occurs at repeated high dose levels of cinnamaldehyde.

Execrition

After 24 hr, >80% of the radioactivity is recovered in the urine and <7% in the feces from all groups of rats, regardless of dose level.